The company intimated its participation in an Analyst/Institutional Investor Meet, specifically one-to-one and group investor meetings.
The event is scheduled for October 19, 2026, and October 20, 2026, in Singapore.
The mode of the meeting is physical.
The stated purpose is investor meetings, though no specific discussion topics (e.g., results, strategy) are detailed.
The disclosure is made pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company explicitly stated that no unpublished price sensitive information (UPSI) is proposed to be shared at the event.
The schedule is noted as subject to change due to exigencies.
Management participants and their designations are not disclosed in the announcement.
The company did not indicate if a presentation, deck, transcript, or recording would be made available, but noted that the information will be available on its investor website.
Additional Notes Section
The document is a regulatory filing submitted to BSE Limited and the National Stock Exchange of India Limited.
No financial data, guidance, or strategic updates were disclosed in this announcement.
The communication includes standard compliance language regarding the non-disclosure of UPSI.
